Skip to main content
Equibles

UBS Group AG

Position in CGTX — Cognition Therapeutics Inc

CIK 1610520 ZURICH, V8
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$251,316
+$192,893 QoQ
Shares Held
218,536
+184.3% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 66 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. CGTX ranks #328 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CGTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $251,316 218,536
2026-03-31 $58,423 76,873
2025-12-31 $100,347 74,332
2025-09-30 $89,152 66,039
2025-06-30 $3,489 11,255
2025-03-31 $0 1
2024-12-31 $28,818 41,112
2024-09-30 $92,795 197,859
2023-06-30 $1,116 610
2022-12-31 $11,640 5,543
2022-09-30 $6,051 3,185
2022-06-30 $1,896 899
2022-03-31 $10,309 3,749
2021-12-31 $23,693 3,749